ArticleBMJ open2020

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Kelvin Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.